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Coronavirus disease (COVID-19), caused by SARS-CoV-2, evolved into a global pandemic in 2020, and the
outbreak has taken an enormous toll on individuals, families, communities and societies around the world. One
practical and effective strategy is to implement rapid case identification based on a rapid testing to respond to this
public health crisis. Currently, the available technologies used for rapid diagnostics include RT-PCR, RT-LAMP,
ELISA and NGS. Still, due to their different limitations, they are not well suited for rapid diagnosis in a variety of
locations. Paper-based devices are alternative approaches to achieve rapid diagnosis, which are cost-effective,
highly selective, sensitive, portable, and easy-to-use. In addition to individual virus screening, wastewater-
based epidemiology has been emerged to be an effective way for early warning of outbreak within the popula-
tion, which tests viral genome sequence to reflect information on the spread and distribution of the virus because
SARS-CoV-2 can be shed into wastewater through the feces and urine from infected population. In this paper, we
describe paper-based device as a low-cost and rapid sensor for both diagnosis and testing of sewage for early
warning of outbreak. More importantly, the device has great potential for real-time detection in the field, without
any advanced facilities or well-trained and skilled personnel, and provides early warning or timely intervention of
an outbreak of pandemic.1. Introduction
The entire world has been faced with a vast pandemic, coronavirus
disease 2019 (COVID-19) since 2019, and this global pandemic is still an
unsolved problem and has caused a significant crisis for global public
health. COVID-19 is a new respiratory infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs
to the family of coronaviruses. There are some other infectious diseases
caused by coronaviruses in history, like severe acute respiratory syn-
drome (SARS) and Middle East respiratory syndrome (MERS) [1]. One
defining characteristic of COVID-19 is that it spreads quickly across the
world, and the outbreak with near exponential growth has put an over-
whelmed strain on health systems around the world. Although countries
around the world have different public health responses to this global
disease because of the different stages of the outbreak, a typical effective
strategy is to identify cases through rapid testing and isolate infected
patients. Therefore, it is of vital importance to adopt COVID-19 testing
that could accurately and rapidly detect infected individuals to reduce
transmission and control outbreaks.
In a short period of time, COVID-19 has evolved into a global. Yang).
rm 25 November 2020; Accepted
vier Ltd. This is an open access apandemic that has had a profoundly negative impact on individuals,
families and societies around the world [2]. There have been profound
changes in people’s daily lives, such as telecommuting, maintaining so-
cial distance, and the inability to freely go out, and many family reunions
events have been cancelled due to the ban on people gathering, like fu-
nerals and weddings. More importantly, the COVID-19 epidemic has
plunged economies around the world into recession because of the
adoption of lockdown measures to control virus transmission. Cultural
activities in society, such as global conferences and events on fashion and
sports, have been disrupted by infectious diseases. In order to alleviate
the unprecedented pressures on individuals, families and societies at this
difficult time, there is an urgent need for developing personal rapid
diagnosis and large-scale screening tools for infections, as well as seeking
effective early warning system for effective intervention and
management.
2. Current state-of-art for COVID-19 diagnostics
Generally, there are mainly two categories of analytical techniques
for COVID-19 detection, and the first type is the molecular approaches for27 November 2020
rticle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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chain reaction (RT-PCR) is the most widely used molecular detection
technique and is regarded as the gold standard for diagnosis of SARS-
CoV-2 virus [3,4]. The first step of RT-PCR assay is to collect biological
fluids that may contain virus strains from the upper and lower respiratory
tract, which is followed by several filtration and separation steps to
isolated RNA [5]. Then, the transcriptase enzyme is used to converse
viral RNA to complementary DNA (cDNA). The next step is the PCR re-
action where DNA undergoes amplification with DNA polymerase. Dur-
ing the amplification, the TaqMan probe with a fluorescent molecule and
a quencher molecule can detect specific viral sequences and generate
fluorescence signal. After dozens of amplification cycles, the system can
detect the intensity of the fluorescent signal, which is proportional to the
virus concentration in the sample.
As a predominant diagnostic method for managing COVID-19
pandemic, RT-PCR is sensitive, specific and reliable, but it still has
some unavoidable limitations. To perform the RT-PCR test, well-trained
professionals, various specialists and expensive instruments are neces-
sary, which is a concern in the developing regions and countries in short
supply [6]. Also, the analysis time of RT-PCR lasts for four to six hours,
and the turn-round time from sample to result usually exceeds 24 hours,
which may be longer when the number of infectious cases dramatically
increases [7]. More importantly, some research indicated that the diag-
nosis of SARS-CoV-2 by RT-PCRmight be false negative at some times [8,
9]. There are many possible reasons for false negative results, and the
primary one is that RNA is easy to degrade, so special handling at a low
temperature is needed in collection, storage, transfer, purification and
processing [6].
Another molecular method that uses isothermal amplification to
detect viral nucleic acids, for example, reverse transcription loop-
mediated isothermal amplification (RT-LAMP). RT-LAMP depends on
its ability to amplify the complementary DNA of coronavirus at a constant
temperature, and the amplification needs four primers with high speci-
ficity to detect target sequences [7]. The LAMP reaction is accompanied
by magnesium pyrophosphate precipitation when viral sequences are
amplified, and this byproduct can increase the turbidity of the sample [3,
4]. Therefore, it is possible to measure the turbidity change or employing
intercalating dyes that can cause visible color change based on the in-
crease in turbidity to monitor the amplification in real time. Since the
amplification condition is at a constant temperature, this approach does
not require high-cost reagents or equipment, which may reduce some
financial pressures and allow testing to be carried out outside the labo-
ratories [10]. Besides, due to the high specificity and high sensitivity,
Lamb et al. suggest the use of RT-LAMP test significantly shortens the
detection time to about 30 min, which is beneficial for rapid detection
[11].
Apart from molecular approaches for viral nucleic acid detection, an
alternative diagnose strategy is the used of immunological assays to
detect various antibodies specific to SARS-CoV-2 antigens, and these
assays aimed to monitor disease progression and identification of past
infection [3,4]. Enzyme-linked immunosorbent assay (ELISA) is currently
the most common antibody detection in use. It uses a multi-well plate
coated with viral proteins, which can specifically bind antibodies from
blood samples [12]. As the other antibodies labelled with enzymes are
introduced subsequently, a colourimetric or fluorescent-based signal is
produced.
The next-generation sequencing (NGS), also known as high-
throughput sequencing (HTS), is another method for implementing
COVID-19 diagnosis. This technology can determine the genome
sequence of more than 1 million base pairs in a single sequencing, thus it
can be used to detect the gene sequence of a virus in a short time. Pre-
viously, whole-genome sequencing method was used to identify the
transmission of methicillin-resistant Staphylococcus aureus (MRSA) in
community and hospital, and this technology showed significantly high
precision and traceability in patients compared to other standard
infection-control techniques [13]. In 2020, the FDA approved one2
product named Illumina COVIDSeq Test. This amplicon-based NGS test
employs 98 DNA fragments to cover the roughly 30 kilobases in the
SARS-CoV-2 genome, and the detection is usually completed within 12
hours [14]. Although the sequencing technique has high accuracy in
virus diagnosis, it requires a relatively long detection time and the in-
struments and reagents used require high costs.
3. Wastewater-based epidemiology for early warning of COVID-
19 outbreak
Although these mentioned assay techniques are evolving with
improved approaches and can be well applied in COVID-19 diagnosis, it
is still an enormous challenge for the globe to screen every suspicious
infection in such a critical time. To address this issue, it is believed that
wastewater-based epidemiology (WBE) is an alternative method for
predicting virus spread and early warning pandemic by detecting path-
ogens in wastewater [15]. Gormely et al. reported that the sanitary
plumbing system was one potential spread route for SARS-CoV-1 if
infected patients were found in the community [16], and similarly
SARS-CoV-2 virus can be transmitted by aerosol or water droplets.
Additionally, SARS-CoV-2 biomarkers can be detected in the sewer sys-
tem, because the virus can be isolated from the infected patients’ feces
and urine [17]. According to the results of various studies, which
investigated fecal samples from infected patients, the positive rate of
SARS-CoV-2 in patients’ feces varied from 15 to 83% [18]. Especially,
one study highlighted that the virus in feces persisted positively even
after the nasopharyngeal testing had become negative [19]. Conse-
quently, the analysis of wastewater in communities is a potential method
to track infected people, and the epidemiology of the communities can be
monitored via sewage pipe networks.
The concept of wastewater-based epidemiology is to give compre-
hensive health information on communities, and the schematic diagram
of WBE is presented in Fig. 1 [20]. Initially, WBE was used to estimate
drug abuse in the community. By analyzing certain target drug residues
in sewage, it is possible to estimate and monitor the trends of illegal drug
consumption [21]. Other biological indicators in wastewater, such as
pharmaceuticals, and personal care products, markers of population size,
and industrial chemicals, can also be quantitively and qualitatively
determined to obtain epidemiologic data for addressing public health
issues [22]. Similarly, viruses are another important biomarker for
wastewater -based epidemiology. Since viruses cannot grow outside the
host cells, the level of viruses in wastewater is directly proportional to the
concentration of viruses in the excrement of the corresponding popula-
tion [23]. Through the analysis of sewage, the changes in virus concen-
tration and diversity can be obtained, which are useful information for
assessing the temporal and spatial patterns of virus infection in the
community. Significantly, adopting this method in the early stage of the
viral outbreak can determine where the virus starts to develop and spread
[1]. Correspondingly, early warning and intervention can be taken based
on these findings. Considering all these merits of WBE, Bivins et al. call
for global collaboration to improve detection approaches for COVID-19
in wastewater [24].
During the COVID-19 pandemic, there are several techniques for
sewage analysis, and PCR-based methods have been the prime tech-
niques in the application. Many countries reported the presence of SARS-
CoV-2 RNA in sewage by using RT-PCR assays because as mentioned
before, this diagnostic method provides high specificity and sensitivity.
The Netherlands tested three nucleocapsid genes (N1–N3) and one the
envelope gene (E) of SARS-CoV-2 in the sewage samples from six cities
and airports [25]. The results showed that the target RNA was not
detected before the first confirmed infection case in February. Never-
theless, due to the prevalence of COVID-19 in March, the target nucleic
acid signal increased significantly. A study conducted in Massachusetts
using RT-PCR also showed that the observed viral titers were higher than
the expectation based on the confirmed clinic cases in March [26]. One
explanation for this result may be that the clinic testing is limited in
Fig. 1. The schematic diagram of WBE [20].
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detection in sewage can be regarded as an early warning tool for the
presence and prevalence of COVID-19 infection and a supplementary
method for clinical testing.
Although PCR-based methods are mainstream ones for sewage anal-
ysis, some disadvantages of PCR assay earlier mentioned limit its global
application. When it comes to WBE, the ideal wastewater analysis
method is to perform rapid virus detection at the wastewater collection
outlets so that the transmission of the virus can be monitored in real time
and early warnings can be implemented in time. Since PCR-based
methods are time-consuming and need sophisticated equipment and
centralized laboratories, it is necessary to develop other methods that
have high specificity and sensitivity, but also have the advantages of low
cost, rapidness, accuracy and simplicity [1]. One promising method that
can be applied for WBE is a paper-based microfluidic device. This
portable diagnostic device offers the potential for a medical diagnosis
that can be used in resource-limited areas and urgent situations.
4. Paper-based devices
Paper has been used as a diagnostic tool for a long time, and the most
common examples are test papers, such as pH test strips and urine test
strips. The urine test strips are designed to detect some metabolic prod-
ucts in urine, which are common pathological indicators (e.g., protein,
glucose, and salt) [27]. Due to the different concentrations of metabolic
products, various color changes happened on the paper, and this can be
read by comparing to the standard test strips.
With the improvement of rapid analysis methods, lateral flow assay
(LFA) was introduced into paper-based diagnostic procedures and
updated paper-based devices. One typical LFA device consists of four
parts, involving sample pad, conjugate pad, nitrocellulose membrane and
absorbent pad [28]. There are two types of LFA assay frequently used and
they are competitive assay and sandwich assay. The former one is used to
test low molecular weight or single epitope analytes, while the sandwich
format is more suitable for analytes presenting several epitopes. When
using competitive assay, if there is no analyte in the sample, unbound
antibodies will bind to immobilized molecules on a sheet of the plastic
backing, causing visual signal. On the contrary, a visual change can be
observed on sandwich assay paper when the analyte is present in the
sample. LFA, as a paper-based assay, gain popularity in the detection of
drugs, toxins, pesticides, bacteria and viruses due to its simplicity and
rapidity.3
Currently, the latest paper-based devices refer to microfluidic devices
that take advantage of paper as a substrate for various bioassays, and
paper-based microfluidic devices are powerful tools for pathogen anal-
ysis and determination of infection transmission. The reason for choosing
paper as the substrate is that it is affordable, light, easily accessible and
disposable [15]. To fabricate paper-based microfluidic devices for
different detection aims, paper made up with various material are picked
up, such as cotton cellulose and nitrocellulose [27]. Also, there are
several production approaches for paper-based microfluidic devices,
including photolithography, polydimethylsiloxane (PDMS) plotting,
inkjet printing, wax printing, wax screen printing, wax dipping, and
plasma treatment.
When the biomolecules to be tested are nucleic acids, the frequently
used approach is wax printing. The wax printer can print this analytical
paper with wax channels that can restrict and guide samples and re-
agents, and the entire detection process of genetic materials, from
extraction, enrichment, purification, elution, amplification, to visual
detection are combined on this paper [15]. It is not required to have
external power or pump supply for conducting paper-based testing,
instead only a few simple folds of the device are necessary to complete
the detection. Due to the simple operation and ease of fabrication,
paper-based microfluidic devices can potentially be an alternative of PCR
for rapid and accurate diagnosis of infectious disease with a fast turn-
around time, when there is a lack of skilled professions and high-cost
equipment.
Efforts have been made to improve paper-based microfluidics and
studies showed that this technique meets prime demands of field-based
diagnostics and can be used for infectious disease prevention, control
and precise diagnosis. Kaarj et al. developed a platform utilizing RT-
LAMP, a more straightforward amplification method requiring a con-
stant temperature, to assay Zika virus (ZIKV), and the whole process was
completed on a wax printed paper microfluidic chip as shown in Fig. 2
[29].
When the sample (urine or blood plasma) was added to the device,
the paper fibers had a capability to filter large size molecules as a pre-
treatment. In addition, the viral RNA with strong negative charges
spontaneously moved to the end of the channel, while proteins and other
cell fragments were remained because of the strong negative polarity of
cellulose fibers in paper. The target nucleic acids were amplificated on a
simple hot plate, and the amplification results can be obtained by
observing the intensity of the added pH indicator dye. The LAMP-based
paper devices have also been used to diagnose rotavirus A, the most
Fig. 2. The schematic diagram of paper microfluidic RT-LAMP assay for ZIKV [29].
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The nucleic acid extraction and thermostatic RNA amplification were
completed on a simple paper disc, and the entire process only took about
half an hour. The positive amplification result of rotavirus A can be read
immediately with the naked eye, that is, the rose-red on the glass fiber
paper.
The previously studies were to complete the detection of pathogens
using paper-based microfluidic devices in the laboratory. In addition, one
study practically used this point-of-care diagnostic tool in rural Uganda
to quickly diagnose malaria for residents [31]. The testing could give
results in approximately 50 min by analyzing multiplexed RNA se-
quences of pathogens, which greatly shortened the diagnosis time
compared with the high-cost PCR analysis. Besides, the sensitivity of this
diagnostic origami device was higher than expected, 98% of people with
malaria can be detected, while the detection rates of other field-based,
benchmark techniques, including optical microscopy and
industry-standard rapid immunodiagnostic tests, were 86% and 83%
respectively. Like PCR assay, these field-based techniques required
experienced professions to perform.
Paper-based microfluidic devices were demonstrated to be rapid,
affordable, portable and easy to handle in field-based diagnosis, and were
feasible for use in resource-poor areas. Another advantage of the paper
analytical tool is that it is thin and lightweight, thus this device tends to
be easy to stack, transport and store [15]. Additionally, after using
paper-based microfluidic device to complete the diagnosis, it can be
disposed of by incineration, which possibly reduces the risk of causing
contamination. As a result, this novel analytical device with various
merits has excellent potential to be applied to respond to the COVID-19
pandemic, thereby enabling rapid and on-site virus detection for imme-
diate diagnosis and wastewater-based epidemiology investigation.
5. Paper-based device for diagnostics and testing wastewater for
early warning of COVID-19
5.1. Rapid diagnosis for COVID-19
One characteristic of COVID-19 is spreading quickly around the
world, and a critical solution to this public health issue is to offer rapid4
and accurate screening for infected patients whether they have symptoms
or not. Based on a large-scale screening of infection cases carried out
early in the epidemic, confirmed cases can be treated in time, reducing
severe cases, easing the burden on the medical system and managing the
epidemic. Since paper-based microfluidic devices have been developed
to diagnose infectious diseases before, it holds a great potential to meet
the demand for rapid diagnosis for COVID-19 as well.
The first type of rapid diagnosis is a nucleic acid-based assay, and it is
possible to design an analysis tool that can identify nucleic acids in a
short time by applying various isothermal amplification techniques to
paper-based devices.
Some paper-based devices have been focused on LAMP detection of
nucleic acids in infectious diseases, which could be adopted to detect
COVID-19 nucleic acids. For instance, Xu et al. presented a paper-origami
device for multiplex detection of Plasmodium falciparum, Plasmodium
vivax and Plasmodium pan [32]. DNA extraction, LAMP, and fluorescence
detection was integrated for target detection from whole blood.
Origami-paper based LAMP assay can identify between Plasmodium fal-
ciparum and Plasmodium vivax infections, which can guide appropriate
treatments for corresponding infections. A paper microfluidic device has
been developed for multiplex detection of three bovine infectious
reproductive diseases in semen samples and tested in a rural India farm
[33]. Pathogen DNA was extracted from bovine herpes virus-1 (BoHV-1),
Brucella and Leptospira, then amplified by LAMP and detected fluo-
rescently (Fig. 3). The detection limits for three pathogens were as low as
50 Leptospira organisms, 50 CFU Brucella, and 1 TCID50 BoHV-1, which
make paper microfluidic devices suitable for on-site diagnosis of infec-
tious diseases. Choi et al. developed an integrated paper-based biosensor
for nucleic acid testing [34]. The FTA card and glass fiber were integrated
into a lateral flow strip for sample addition, washing, paper-based LAMP,
visual detection or smartphone quantification. A handheld
battery-powered heating device was used for on-site LAMP tests. Detec-
tion limits of 10–1000 CFU mL1 were measured for Escherichia coli in
spiked drinking water, milk, blood and spinach. This integrated
paper-based biosensor is suitable for transformation into a device for
rapid on-site RT-LAMP detection of COVID-19 nucleic acids.
Recently, rapid progress has been made in RT-LAMP enabled
isothermal amplification methods for COVID-19 diagnosis [35]. The
Fig. 3. The schematic diagram of the paper device for the detection of BoHV-1, Brucella and Leptospira [33].
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that can detect the RNA-dependent RNA polymerase (RdRp) gene from
nasopharyngeal and throat swabs through isothermal amplification,
and get a LOD of 125 genome equivalents mL1 in less than 15 min
[36]. Another team adopted the RT-LAMP and the clustered regularly
interspaced short palindromic repeats (CRISPR) technique to detect
SARS-CoV-2 in respiratory swabs within 40 min, and the diagnosis
result can be known using the LFA, which is a conventional type of
paper-based device [37]. This work has expanded the possibility of
CRISPR-based DETECTR technology for on-site COVID-19 diagnosis
with the investigations on portable microfluidic cartridges and
lyophilized reagents. Therefore, it is promising to use paper-based
devices such as LFA to detect the LAMP reaction products, and the
whole process can be completed on a paper device for a point-of-care
coronavirus disease diagnosis. Notably, the emergence of the
paper-based devices for rapid diagnosis could be a massive improve-
ment for places where resources are limited and the public health
system is overwhelmed.
In addition to detecting nucleic acids to screen infected patients,
paper-based devices can also be used to detect antibodies to help infec-
tious disease diagnosis. Singh et al. reported a colorimetric paper-based
sensor to detect pan malaria and Plasmodium falciparum based on a
dye-based chromogenic reaction [38]. The instrument-free technique
could be implemented for quantitative and qualitative determination of
malaria by visual readout or a camera integrated software. In another
work, a deployable bioplasmonic paper-based device was fabricated to
detect anti-ZIKV-NS1 Immunoglobulin G (IgG) and IgM using LSPR [39].5
The device was validated for target detection in serum samples, indi-
cating great potential for effective determination of anti-ZIKV-NS1 IgG
and IgM in the complex physiological environment with multiple inter-
fering substances. When it comes to COVID-19, a variety of lateral flow
test strips have been employed for COVID-19 diagnosis, such as Cellex
qSARS-CoV-2 IgG/IgM Rapid Test, Wondfo SARS-CoV-2 antibody test,
Mammoth Biosciences SARS-CoV-2 DETECTR and SGTi-flex COVID-19
IgM/IgG [40]. For example, a lateral flow immunoassay was presented
for combined detection of SARS-CoV-2 IgG and IgM in human blood in
less than 15 min during various infection stages, showing in Fig. 4 [41].
The detection device comprises of a sample pad, a conjugate pad, a
nitrocellulose membrane, an absorbent pad and an adhesive card. The
clinical efficacy uses was demonstrated by performing clinical tests on
different venous and fingerstick blood samples with a sensitivity of
88.66% and a specificity of 90.63%.
Kasetsirikul et al. designed a colorimetric paper-based assay to
detect SARS-CoV-2 humanized antibody, which is a cheap and acces-
sible serological assay [42]. This development combined a common
serological assay method, ELISA, with the paper-based devices, by
coating the recombinant SARS-CoV-2 nucleocapsid antigen on the
paper analysis tool. The target antibodies from human serum could be
captured by the recombinant antigen on the device, forming an
immunological complex. This complex formation could be read out
through a colorimetric reaction, 3,30,5,50-tetramethylbenzidine sub-
strate with horseradish peroxidase (TMB/HRP), and the entire process
took 30 min, which was much shorter than a conventional ELISA assay
(usually one to 2 h).
Fig. 4. The schematic illustration of SARS-CoV-2 IgG and IgM test [41]. (A) The detection device. (B) Different test results.
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The sewage analysis is a cost-effective and highly efficient method to
determine the infectious cases, monitor the virus transmission and
manage the pandemic. As mentioned before, PCR is still the main method
used to detect SARS-CoV-2 in wastewater [44]. However, this kind of
detection method that requires sophisticated instruments, complicated
operation and long-time analysis is not suitable for real-time detection on
the wastewater site. As an alternative approach, the paper-based device is
suggested for on-site inspection of wastewater. Despite the fact that
various kinds of substances contained in wastewater, it is believed that
the paper-based device is capable of detecting pathogens from sewage.
Yang et al. reported a “sample-to-answer” tool to analyze the waste-
water in communities, tracking biomolecular agents and genetic infor-
mation [43]. The platform still took advantage of LAMP as a method of
nucleic acid amplification. After removing solid impurities in the original
wastewater and extracting and enriching DNA, it performed quantitative
monitoring of the target genetic material. Finally, The LFA was used to
present the visual assay result. The time to finish this assay at the sample
collection point was 45 min, and no expensive equipment or experienced
operators were required.
Similar paper devices may also become sewage analysis tools for the
COVID-19 outbreak. In view of the high selectivity, high sensitivity, rapid
response time and cost-effectiveness of this technique, it is believed that
paper-based devices have the capability to be applied to the on-site
detection of wastewater, providing real-time and continuous informa-
tion. Based on this information, the local epidemiology of SARS-CoV-2
can be analyzed to better manage the infection situation in the commu-
nity, such as early warning of epidemics or isolation of infected people.5.3. Conclusion and future outlooks
In summary, during the COVID-19 outbreak, isolating the infected
people through effective diagnostic methods is a universal method to
slow the spread of the disease, and the main method used today is RT-
PCR. Compared with RT-PCR, paper-based device is an analytical tool
that can provide rapid and accurate biomolecular detection. More
importantly, this detection method does not require laboratory-grade6
instruments and professional operators to complete it. The develop-
ment of this cheap and rapid diagnosis method has brought hope to
control the epidemic in some resource-limited regions and developing
countries.
Besides, wastewater-based epidemiology is a new and promising
mornitoring mechanism for managing epidemics at the community and
population level, because the analysis of sewage can obtain the infection
situation inside the area and facilitate early warning of infectious dis-
eases, so as to carry out effective prevention and intervention. In order to
continuously detect viral RNA in sewage in real time, an on-site detection
method is needed. The paper-based device, such a portable analytical
tool, can meet the requirements for wastewater-based epidemiology, and
detect biomolecules in sewage containing complex matrices. Based on
the analysis results, it is possible to give an early warning of infectious
disease, identify SARS-CoV-2 carriers, determine the infection status in
the community, and finally control the epidemic through timely measure
and intervention.
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